Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Docetaxel & Non-small-cell lung cancer (NSCLC) (Squamous Cell Carcinoma), Docetaxel is approved by both FDA and EMA for NSCLC (e.g., Non-small-cell lung cancer (NSCLC) (Squamous Cell Carcinoma)), and the labeling is histology‑agnostic, so squamous cell carcinoma falls within the approved NSCLC population, both for monotherapy (post‑platinum) and for cisplatin–docetaxel first‑line regimens in advanced disease (1)
(1)
see also:
[Docetaxel & Non-…